| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $15.7M | +6.6% | -33.0% |
| SG&A Expense | $6.0M | -62.7% | -26.7% |
| Operating Income | -$21.6M | +29.5% | +31.4% |
| Pre-tax Income | -$20.3M | +22.3% | +31.2% |
| Net Income | -$20.3M | +22.3% | +31.2% |
| EPS (Basic) | -$0.33 | +45.0% | +62.9% |
| EPS (Diluted) | -$0.33 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.0M | +15.5% | -73.9% |
| Current Assets | $127.8M | -8.8% | -19.9% |
| Total Assets | $143.8M | -18.3% | -17.3% |
| Current Liabilities | $17.3M | -45.3% | -35.6% |
| Total Liabilities | $23.0M | -39.2% | -33.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$78.5M | — | — |
| Capital Expenditures | $397K | — | — |
| Investing Cash Flow | $11.4M | — | — |
| Financing Cash Flow | $73.0M | — | — |
| Free Cash Flow | -$78.9M | — | — |
| +45.0% |
| +62.9% |
| $120.8M |
| -12.6% |
| -13.3% |